Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Aptose Biosciences ( (TSE:APS) ) has issued an announcement.
Aptose Biosciences said proxy adviser Institutional Shareholder Services has recommended that investors back its proposed plan of arrangement under which Hanmi Pharmaceutical and its subsidiary would acquire all Aptose shares they do not already own for C$2.41 in cash, a 28% premium to the company’s 30-day volume-weighted average price. ISS also supported Aptose’s planned corporate continuance from the Canada Business Corporations Act to the Alberta statute, and the board is unanimously urging shareholders to vote in favor of both the transaction and the continuance ahead of a reconvened virtual special meeting on March 31, 2026, with closing still contingent on shareholder, court and TSX approvals.
The most recent analyst rating on (TSE:APS) stock is a Hold with a C$2.50 price target. To see the full list of analyst forecasts on Aptose Biosciences stock, see the TSE:APS Stock Forecast page.
Spark’s Take on APS Stock
According to Spark, TipRanks’ AI Analyst, APS is a Neutral.
The score is held back primarily by very weak financial performance (no revenue, ongoing cash burn, negative equity and rising debt). Positive corporate catalysts (promising trial results and a pending acquisition) provide meaningful offset, while technical indicators are mixed-to-weak and valuation metrics are not supportive due to negative earnings and no dividend.
To see Spark’s full report on APS stock, click here.
More about Aptose Biosciences
Aptose Biosciences Inc. is a biotechnology company listed on the Toronto Stock Exchange and OTC markets, focused on developing oncology therapies. The company operates in the life sciences sector, targeting hematologic malignancies and related cancer indications through targeted small-molecule drug candidates.
Average Trading Volume: 4,242
Technical Sentiment Signal: Sell
Current Market Cap: C$5.67M
See more data about APS stock on TipRanks’ Stock Analysis page.